Integra LifeSciences Holdings Corporation
DE ˙ DB ˙ US4579852082
13,30 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityDE:IL3 / Integra LifeSciences Holdings Corporation
InstitutionHsbc Holdings Plc
Latest Disclosed Ownership69,728 shares
Latest Disclosed Value $ 640,694
Hsbc Holdings Plc reports 0.82% decrease in ownership of IL3 / Integra LifeSciences Holdings Corporation

On April 30, 2026 - Hsbc Holdings Plc filed a 13F-HR form disclosing ownership of 69,728 shares of Integra LifeSciences Holdings Corporation (DE:IL3) valued at $550,851 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 20, 2026 disclosing 70,305 shares of Integra LifeSciences Holdings Corporation. This represents a change in shares of -0.82% during the quarter. The current value of the position is $927,382 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 69,728 -577 -0.82 641 -27.11 0.0000
2026-03-20 2025-12-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 70,305 70,305 879 0.0000
2026-03-06 2025-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 70,305 70,305 879 0.0000
2025-08-13 2025-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -100.00 0
2025-05-14 2025-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 40,323 30,331 303.55 887 290.31 0.0005
2025-02-14 2024-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 9,992 -617 -5.82 227 18.85 0.0001
2024-11-14 2024-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 10,609 10,609 191 0.0001
2024-02-12 2023-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -19,801 -100.00 0 -100.00
2023-11-13 2023-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 19,801 -20,838 -51.28 759 -54.83 0.0008
2023-08-11 2023-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 40,639 10,995 37.09 1,678 -0.71 0.0017
2023-05-15 2023-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 29,644 29,644 1,690 0.0020
2023-02-14 2022-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -97,460 -100.00 0 -100.00
2022-11-14 2022-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 97,460 36,321 59.41 4,220 26.61 0.0069
2022-08-11 2022-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 61,139 47,674 354.06 3,333 278.32 0.0047
2022-05-16 2022-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 13,465 4,131 44.26 881 40.06 0.0011
2022-02-11 2021-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 9,334 -203 -2.13 629 -4.55 0.0006
2021-11-12 2021-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 9,537 -6,625 -40.99 659 -40.09 0.0007
2021-08-13 2021-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 16,162 9,225 132.98 1,100 129.17 0.0012
2021-05-14 2021-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 6,937 -2,069 -22.97 480 -17.95 0.0006
2021-02-25 2020-12-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 9,006 -1,880 -17.27 585 12.93 0.0008
2021-02-12 2020-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 9,006 -1,880 585 138.9005
2020-11-12 2020-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 10,886 2,448 29.01 518 30.48 0.0008
2020-08-14 2020-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 8,438 -6,428 -43.24 397 -39.48 0.0008
2020-05-15 2020-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 14,866 14,866 656 0.0015
2019-08-13 2019-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -7,879 -100.00 0 -100.00
2019-05-15 2019-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 7,879 7,879 439 0.0008
2019-02-13 2018-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -4,956 -100.00 0 -100.00
2018-11-13 2018-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,956 -17,194 -77.63 327 -77.04 0.0005
2018-08-10 2018-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 22,150 17,913 422.78 1,424 505.96 0.0025
2018-05-11 2018-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,237 4,237 235 0.0003
2017-05-15 2017-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -6,831 -100.00 0 -100.00
2017-02-09 2016-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 6,831 6,831 586 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.